Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Eli Lilly

Stocks Soar Before the Open on Upbeat Microsoft and Meta Results, More Big Tech Earnings on Tap

June S&P 500 E-Mini futures (ESM25) are up +1.18%, and June Nasdaq 100 E-Mini futures (NQM25) are up +1.68% this morning as forecast-beating quarterly results from Microsoft and Meta boosted sentiment.

Viagra and Mounjaro panic-buying could explain Ireland's 200% export surge to U.S.

Viagra and Mounjaro panic-buying could explain Ireland's 200% export surge to U.S.

U.S. multinational activity propelled the Irish economy to 3.2% growth in the first quarter, as Trump fears come into focus.

Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions

Ozempic maker spending more than $3m to lobby fat cats in Washington as weight-loss drugs faces regulatory decisions

Novo Nordisk has hired multiple lobbying firms to persuade lawmakers to take a harder line on companies producing versions of the drugs that have not been approved by the FDA

The Independent UK

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

2 ‘Strong Buy’ Stocks to Buy on Plans to Increase American Manufacturing

Two checkered names from diverse industries are looking to bolster their manufacturing capabilities in the U.S. Here's how they stack up as investment ideas.

Trade war with China to hit US healthcare

Without a carve-out for tariff exceptions for pharmaceuticals, prices will skyrocket for US patients, experts warn.

Eli Lilly Nails Oral GLP-1 Trial—Here’s What It Means for LLY

Take a deep dive into Eli Lilly's latest clinical GLP-1 results that sent shares soaring. The company has a big opportunity to serve needle-phobic patients.

Novo Nordisk Pops After Leapfrogging Eli Lilly With An Obesity Pill

Novo Nordisk stock popped Tuesday on reports it's asked the FDA to approve its weight-loss pill, an oral version of Wegovy.

Investors Business Daily

inkl

Read news from The Economist, FT, and more,
with one subscription

Eli Lilly's Quarterly Earnings Preview: What You Need to Know

Eli Lilly's Quarterly Earnings Preview: What You Need to Know

Eli Lilly is scheduled to report its first-quarter results next month, and analysts expect a significant double-digit earnings growth.

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Swiss drugmaker Roche to invest $50bn in US in effort to dodge Trump tariffs

Company says it will create 12,000 jobs in manufacturing and R&D over next five years

The Guardian - UK

Eli Lilly Earns Membership In 95-Plus Composite Rating Club

Eli Lilly Earns Membership In 95-Plus Composite Rating Club

The IBD SmartSelect Composite Rating for Eli Lilly rose from 87 to 97 Monday.

Investors Business Daily

Goldman Sachs Just Upgraded This Blue-Chip Stock. Should You Buy It Now?

Goldman Sachs Just Upgraded This Blue-Chip Stock. Should You Buy It Now?

With a strong pipeline, this pharmaceutical powerhouse is positioning itself as a dominant force in the future of medicine.

Daily weight-loss pill may work as well as Ozempic and could replace injections

Daily weight-loss pill may work as well as Ozempic and could replace injections

Patients in a trial taking orforglipron lost an average of 7.2kg over nine months

The Independent UK

Dow Jones Futures: Netflix Earnings Crush Views After Weekly Market Losses. Palantir, MercadoLibre Setting Up.

Dow Jones Futures: Netflix Earnings Crush Views After Weekly Market Losses. Palantir, MercadoLibre Setting Up.

The major indexes fell in the holiday-shortened week after hitting resistance. It's still a market correction. Netflix

Investors Business Daily

Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth: Weekly Review

Stock Market Tumbles On Nvidia Export Curbs, Fed Chief Powell, UnitedHealth: Weekly Review

The stock market sold off this week, with Nvidia AI chip export curbs, UnitedHealth guidance and Fed chief Jerome Powell's comments in focus.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Guardian - UK

New daily weight-loss pill shows success at clinical trial

Orforglipron also reduced blood sugar levels in participants with type 2 diabetes

Experimental daily pill found to aid weight loss in what could be alternative to jabs like Ozempic

Other weight loss drugs must be injected, meaning the new pill from pharmaceutical giant Eli Lilly could become patients’ top choice if it is approved.

Investors Business Daily

Eli Lilly Rockets 14% After Solidifying Its Lead For A Weight-Loss Pill

Eli Lilly stock jetted higher Thursday after the company said its diabetes and weight-loss pill helped patients lose up to 16 pounds.

Analysts Love These 2 Stocks to Buy for Q2

Investors could snag these two stocks as BofA flags the companies as well-positioned winners in an uncertain quarter.

Get all your
news in one place.

100’s of premium titles.
One news app.

Hims’ Weight Loss Expansion: Real Growth or Just Hype?

Will Hims and Hers' addition of Eli Lilly's Zepbound to its weight loss platform be a big new growth driver? Or, is this development all bark and no bite?

Investors Business Daily

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Broadcom Results Ahead

Netflix is among the stocks with most bullish analyst ratings.

Investors Business Daily

Trump Tariff News: New Tariffs Begin, China Retaliates; Treasury Yields Spike While Delta, Walmart Pull Guidance

Trump tariff news: President Trump's latest tariffs took effect Wednesday while China stepped up retaliation. Treasury yields are worrisome. Walmart and Delta Air pulled some guidance, citing tariff uncertainty.

Investors Business Daily

Humana, UnitedHealth, Other Insurers Jump On Medicare Advantage Payment Hike

The Trump administration says it will raise Medicare Advantage payments sharply, good news for Humana, UnitedHealth and other health insurers.

Investors Business Daily

Eli Lilly, Novo Stocks Dive After Medicare Excludes Weight-Loss Drugs

The Trump administration finalized new Medicare and Medicaid policies late Friday, but left out weight-loss drugs. Eli Lilly stock skidded.

Investors Business Daily

Hims Stock Jumps After Adding Eli Lilly's Obesity Drug To Its Platform

Hims stock surged Tuesday after the compounding pharmacy said it would sell Eli Lilly's branded weight-loss drug on its telehealth platform.

Experimental Drug Shows Promise In Eliminating Hard-To-Treat Deadly Cholesterol

A single dose of lepodisiran dramatically lowered dangerous lipoprotein(a) levels for up to a year, offering new hope for heart disease treatment.

People

119,570 stories

Mark Zuckerberg

Robert F. Kennedy Jr

From analysis to the latest developments in health,
read the most diverse news in one place.

inkl

Organisations

US Federal Reserve

the White House

inkl

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

276,764 stories

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.

Download on the AppStore

Get it on Google Play